Skip to main content
. 2021 Apr 24;19(5):241. doi: 10.3390/md19050241

Figure 6.

Figure 6

The structures of the cyanobacterial metabolites as drug leads against SARS-CoV-2, (a) the sequence of amino acids in 40, (b) Antillatoxin (41), (c) Curacin A (42), (d) Cryptophycin 52 (43).